What does GHK-Cu cost in each channel?
Prices in US dollars at the verification date. Ranges are published list or program prices where a primary source exists; notes say when a figure is a typical market range instead.
| Channel | Price (USD) | Notes |
|---|---|---|
| With insurance | Not published | Not covered. Medicare Part D and commercial pharmacy benefits cover FDA approved drugs for accepted indications; compounded or unapproved peptides are paid in cash. Over the counter cosmetic serums and creams containing GHK-Cu are retail cosmetics, typically about $20 to $100 per bottle, and are not insurance items. [3] [4] |
| Compounded pharmacy | Not published | No lawful compounded price for injectable GHK-Cu. FDA's list dated April 22, 2026 shows the injectable GHK-Cu nomination as withdrawn, so it is in no 503A category, and it is not on the 503A bulks list or a component of an approved drug, so a 503A pharmacy has no federal basis to compound it from bulk. Non-injectable GHK-Cu is different: it is in FDA's 503A Category 1 (under evaluation), where FDA does not intend to act against compounding from a registered manufacturer's ingredient with a certificate of analysis when all 503A conditions are met. Advertised clinic prices are not a comparable price, and products sold as research chemicals for human use are unapproved drugs. [1] [2] [5] |
Why is there no price for injectable GHK-Cu?
Licensed compounding pharmacies, clinics, and telehealth prescribers openly offer many unapproved peptides, and prescribers write prescriptions for them. [6] [7] [8]
Clinics and telehealth programs may quote you a cash price for injectable GHK-Cu. PeptideAgent lists none, for two reasons. There is no injectable GHK-Cu product to price: none is FDA approved, and a pharmacy has no federal basis to compound it. [1] [2] [9] A quoted price is for a product FDA has not checked for safety, effectiveness, or quality, so it is not the price of a reviewed drug. [10]
If you're going ahead anyway: the checklist on the GHK-Cu page. These steps lower some risks. They do not make the product safe, and they do not give a pharmacy a federal basis to compound injectable GHK-Cu, with or without a prescription. [2]
- Check the pharmacy's license
- What a legitimate prescription and consult look like
- Why this is safer than a research-use-only product
- Questions to ask the pharmacy, the telehealth company, the prescriber, and anyone offering it
What is the list price of GHK-Cu?
There is no drug list price: GHK-Cu is not an FDA approved drug. Topical cosmetic products are lawfully sold without a prescription as long as they make no drug claims, and they are far cheaper than prescription products.
Does insurance cover GHK-Cu?
Not covered. Cosmetic topicals are consumer purchases, and injectable GHK-Cu has no lawful compounded source to bill.
What changes the price?
- No federal basis to compound injectable GHK-Cu from bulk: nomination withdrawn and not on the 503A bulks list; non-injectable GHK-Cu is in FDA 503A Category 1
- Cosmetic topical products, which are lawfully sold without a prescription when they make no drug claims, are a separate market
Frequently asked questions
How much does GHK-Cu cost without insurance?
No lawful compounded price for injectable GHK-Cu. FDA's list dated April 22, 2026 shows the injectable GHK-Cu nomination as withdrawn, so it is in no 503A category, and it is not on the 503A bulks list or a component of an approved drug, so a 503A pharmacy has no federal basis to compound it from bulk. Non-injectable GHK-Cu is different: it is in FDA's 503A Category 1 (under evaluation), where FDA does not intend to act against compounding from a registered manufacturer's ingredient with a certificate of analysis when all 503A conditions are met. Advertised clinic prices are not a comparable price, and products sold as research chemicals for human use are unapproved drugs. [1] [2] [5]
Does insurance cover GHK-Cu?
Not covered. Cosmetic topicals are consumer purchases, and injectable GHK-Cu has no lawful compounded source to bill. [3] [4]
What is the list price of GHK-Cu?
There is no drug list price: GHK-Cu is not an FDA approved drug. Topical cosmetic products are lawfully sold without a prescription as long as they make no drug claims, and they are far cheaper than prescription products.
Related pages
- GHK-Cu: evidence, legality, and access
- BPC-157 vs GHK-Cu (BPC-157 cost)
- TB-500 vs GHK-Cu (TB-500 cost)
- Tendon injury and tendinopathy: peptide evidence
- Skin aging and cosmetic repair: peptide evidence
- Wound healing: peptide evidence
- Hair loss (androgenetic alopecia): peptide evidence
- Where it is legal to get: peptide law by state
- Full cost index
From the blog
- Topical vs injectable GHK-Cu: what the evidence shows
Topical GHK-Cu has small skin studies and is a lawful cosmetic. Injectable GHK-Cu has no human trial and is not on the 503A bulks list. Evidence, absorption, safety, and legality compared.
- Copper peptides for hair: what the studies show
Does GHK-Cu help with hair growth? Copper peptides enlarge hair follicles in lab and mouse studies, but no randomized trial of GHK-Cu alone for hair loss exists. How they compare with minoxidil.
Sources
- [1]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (Category 2 list and withdrawn nominations, content current as of April 22, 2026)FDA
- [2]FDA: Bulk drug substances used in compounding under section 503A of the FD&C Act (links to the Category 1, 2, and 3 lists and the bulks list)FDA
- [3]FDA: Is it a cosmetic, a drug, or both? (or is it soap?)FDA
- [4]Medicare.gov: prescription drug coverage (Part D and outpatient drugs)
- [5]FDA warning letter 735063, August 24, 2026, to an online seller of research-use-only peptides: products labeled research use only were unapproved new drugs (FDA warning letters database)FDA, 2026
- [6]FDA: Compounding inspections, recalls, and other actions (warning letters to compounders)FDA
- [7]FDA warning letter 594743, April 1, 2020, to a state-licensed 503A compounding pharmacy (FDA warning letters database)FDA, 2020
- [8]FDA to telehealth companies: What to know when promoting compounded drugsFDA, 2026
- [9]FDA guidance: Interim policy on compounding using bulk drug substances under section 503AFDA
- [10]FDA: Compounding and the FDA, questions and answersFDA